BioSpace News Archive

Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the appointment of Mark Nibbe as Vice President, Operations.

Ultromics’ EchoGo® Heart Failure, an AI solution for echocardiography with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug Administration (FDA) clearance.

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, today announced positive results for HER2X® in a range of clinical scenarios, demonstrating the test’s reliability.

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced its HiFi sequencing technology will be used in a pilot project for the Children’s Rare Disease Cohorts Initiative at Boston Children’s Hospital.

At the 2022 San Antonio Breast Cancer Symposium, Agendia, Inc., a leader in breast cancer gene expression profiling, will present data demonstrating its proprietary signatures fulfill a critical unmet need for precise, proactive treatment planning for premenopausal women with early-stage breast cancer.

Activ Surgical, a digital surgery pioneer, today announced that it is has received CE Mark approval for its ActivSight™ Intelligent Light (“ActivSight”).

Kurome Therapeutics, Inc., a late pre clinical stage biotech company developing novel IRAK1/4 inhibitors for oncology indications, today announced two abstracts have been accepted for oral and poster presentations at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 9-13, 2022, in New Orleans.

Systems Oncology today announced they will be presenting positive preclinical data on the company’s next generation estrogen receptor positive drug candidate, SERA2 (Selective Estrogen Receptor Activator).

OMNY, Inc. (d/b/a OMNY Health), a leader in compliant data and platform solutions for connecting healthcare stakeholders, today announced a $17 million Series B round led by Chicago Pacific Founders (CPF). Dr. Vance Vanier, MD, Co-Founder and Co-Managing Partner of CPF will join the OMNY Board of Directors.

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, announced that its President & CEO Gerald Commissiong will be presenting at the RHK 2022 Disruptive Growth Conference on Tuesday, December 6th at 12:20pm ET.